Meitav Investment House’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Meitav Investment House’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-22,179	Closed	-$776K	–	483
2019 Q2	$776K	Sell	22,179 -200	-0.9%	-$10.8K	0.05%	185
2019 Q1	$1.25M	Sell	22,379 -19,800	-47%	-$1.07M	0.07%	164
2018 Q4	$2.02M	Sell	42,179 -149	-0.4%	-$8.17K	0.13%	92
2018 Q3	$2.68M	Hold	42,328	–	–	0.13%	99
2018 Q2	$3.82M	Buy	42,328 +5,921	+16%	+$572K	0.17%	89
2018 Q1	$3.82M	Hold	36,407	–	–	0.19%	74
2017 Q4	$4.66M	Buy	+36,407	New	+$4.48M	0.27%	71

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Meitav Investment House's VBIV Position: Q3 2019 in Review

Meitav Investment House sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2019, closing a stake of 22,179 shares — an estimated $776K sold.

Meitav Investment House first reported a position in VBIV in Q4 2017 and held it in 7 quarters. The position peaked at $4.66M in Q4 2017. 70 funds tracked by Wall St. Rank hold VBIV as of Q3 2019.

Meitav Investment House reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2019 after selling out during the quarter.
Meitav Investment House sold 22,179 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2019, an estimated $776K.
Meitav Investment House first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2017 and held it in 7 quarters.
Meitav Investment House's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $4.66M in Q4 2017.
70 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2019.

Based on Meitav Investment House's 13F filing for Q3 2019, filed 14 Nov 2019.